The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to comment on your Request for Information (RFI), which seeks feedback on challenges and opportunities related to social determinants of health. Consistent with our priority of building a more just, equitable health care system, PhRMA believes that diversity, equity, and inclusion are essential to the discovery of new medicines and that people of all ethnic and racial backgrounds should have equitable access to treatment.